Citation Impact
Citing Papers
TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
2015
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
2011
Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2013
Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
2012
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
2014
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
2013
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
2018
Idiopathic pulmonary fibrosis
2017 Standout
Immunological and Clinical Effects of Vaccines Targeting p53‐Overexpressing Malignancies
2011
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
2015
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
2013
Cancer drug resistance: an evolving paradigm
2013 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
2012
Cancer immunotherapy via dendritic cells
2012 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
CD73: a potent suppressor of antitumor immune responses
2012
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Pyroptosis: mechanisms and diseases
2021 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Desirable cell death during anticancer chemotherapy
2010
How to improve the immunogenicity of chemotherapy and radiotherapy
2011
Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse
2013
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Immune microenvironments in solid tumors: new targets for therapy
2011
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
2015 StandoutNobel
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
CD39 and CD73 in immunity and inflammation
2013 Standout
Immunologically augmented cancer treatment using modern radiotherapy
2013
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
2014
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
2015
Differential expression of inflammasomes in lung cancer cell lines and tissues
2015
Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
2010 Nature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Blocking IDO activity to enhance anti-tumor immunity
2012
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer
2013
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity
2011
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes
2016
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Blocking IDO activity to enhance anti-tumor immunity
2011
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of André Ly being referenced
Chemotherapy and radiotherapy: Cryptic anticancer vaccines
2010